Almac, inVentiv announce strategic partnership

By Melissa Fassbender

- Last updated on GMT

The strategic partnership offers clients advanced eClinical technology solutions. (Image: iStock/yurok)
The strategic partnership offers clients advanced eClinical technology solutions. (Image: iStock/yurok)

Related tags Contract research organization Clinical trial

Almac Clinical Technologies, part of the Almac Group, has announced a strategic partnership with the contract research organization (CRO) inVentiv Health.

According to Almac​, the partnership enables both companies to provide clients and sites with “streamlined access​” to clinical trial Interactive Response Technology (IRT) solutions, including Almac’s IXRS®​ technology.

As part of the arrangement, several inVentiv’s​ IRT specialists will also join Almac’s consultancy team.

Matthew Cocking, Director of Marketing at Almac Clinical Technologies, told us the rationale for both organizations was simple: “to provide biopharmacuetical clients with best-in-class products and services via the most effective delivery mechanism possible​.”

Cocking explained inVentiv chose to pursue the development of a strategic partnership after recognizing Almac’s dedication to continued innovation in the IRT space.

This transition will enable inVentiv Health to capitalize on Almac’s technical capabilities of applying best practices to random facilitation of drug trial enrollment and medication management while continuing to provide this service seamlessly to inVentiv’s clients with even greater capacity​,” he added.

Gregory Skalicky, Chief Commercial Officer, inVentiv Health Clinical Division commented in the press release:

We’re committed to accelerating clinical trials and see tremendous value in applying leading technology solutions to streamline the process. This partnership will enable inVentiv Health to enhance its clinical services continuum by offering clients access to Almac’s comprehensive, best-in-class IRT services to unlock further efficiencies in trial study configuration and deployment​.”

inVentiv is not providing any additional comment at this time.

Related news

Show more

Related products

show more

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us

Products

View more

Webinars